Lyell Immunopharma dividends
LYEL dividends
| Ex-dividend | Amount | Yield | Pay date | ||||
|---|---|---|---|---|---|---|---|
This company doesn't provide dividends. | |||||||
Lyell is a T cell reprogramming company dedicated to the mastery of T cells to cure patients with solid tumors. We focus on addressing what we believe are the primary barriers that limit consistent, reliable, and curative responses with adoptive T cell therapy: T cell exhaustion and loss of durable stemness, which includes proliferative capacity, ability to self-renew and ability to differentiate and eliminate solid tumors. We apply our proprietary ex vivo genetic and epigenetic reprogramming technology platforms, Gen-R and Epi-R, to address these barriers in order to develop new medicines with improved, durable, and potentially curative clinical outcomes.
Learning section - What Is a Dividend?
A dividend is the distribution of reward from a portion of the company's earnings and is paid to a class of its shareholders. Dividends are decided and managed by the company's board of directors, though they must be approved by the shareholders through their voting rights